Methods We established lenvatinib-sensitive/lenvatinib-resistant (LS/LR) HCC models and employed multi-omics (proteomics/RNA-seq), chromatin immunoprecipitation, luciferase, and RNA immunoprecipitation assays to map hexokinase domain containing protein 1 (HKDC1) regulation
Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain
Intragastric butyrate decreased food intake, whereas intravenous injection did not lead to any changes
This could be taken as evidence that gastric emptying was similar for both groups, however, we obtained blood glucose levels 1 and 3 h post drinking
These studies highlight the importance of continued treatment for sustained success